PURTIER Placenta Live Stem Cell Therapy (ENGLISH)
If you have other enquiries, please contact us at +65 8200 8227 Email: TrueStemCell@gmail.com PURTIER Placenta Live Stem Cell Therapy has been effective for ...
By: Kim Purtier Placenta
Go here to read the rest:
PURTIER Placenta Live Stem Cell Therapy (ENGLISH) - Video
Our Cell Therapy Center offers advanced patented methods of stem cell treatment for different diseases and conditions. The fetal stem cells we use are nonspecialized cells able to differentiate (turn) into any other cell types forming different tissues and organs. Fetal stem cells have huge potential for differentiation and proliferation and are not rejected by the recipients body more...
Stem cell therapy has proven to be effective for organs and tissues restoration, and for fight against the incurable and obstinate diseases. We treat patients with various diseases, such as diabetes mellitus, multiple sclerosis, Parkinsons disease, Duchenne muscular dystrophy, cancer, blood diseases and many others, including rare genetic and hereditary diseases. Among our patients there are also people willing to undergo anti-aging treatment. Stem cell treatment allows for achieving effects that are far beyond the capacity of any other modern method more...
For over 19 years, we have performed more than 7,500 transplantations of fetal stem cells to people from many countries, such as the USA, China, Italy, Germany, Denmark, UAE, Egypt, Russian Federation, Greece and Cyprus, etc. Our stem cell treatments helped to prolong life and improve life quality to thousands of patients including those suffering from the incurable diseases who lost any hope for recovery.
With Cell Therapy Center EmCell located in Kiev, Ukraine, we have numerous partners in various countries devoted to provide medical advice on EmCell stem cell treatment locally.
We are always open for medical, businessandscientificcooperation.
See more here:
Stem Cell Therapy & Stem Cell Treatment - Cell Therapy Center Emcell
SIKESTON, MO (KFVS) -
Stem cell therapycan bea very controversial issue, but now some veterinarians are using new techniques to harvest those cells.
The cutting edge procedure helps fight degenerative diseases and has only been performed a few times in Missouri.
Experts say regenerative medicine using stem cells is a less invasive and more cost effective alternative for dogs suffering from osteoarthritis and cartilage injuries.
Googus is an 8 year old Boxer mix diagnosed with degenerative myelopathy.
This terminal disease affects the spinal cord causing loss of control in the hind legs.
"Even though they're unable to use their back legs they're still normal in their brain and they just don't understand why they can't walk," said Dr. Stephen Williams, Animal Health Center. "There's just not a good connection and transmission from the nerves to the back legs."
But new technology could slow, if not stop, its progression. Dr. Williams is using stem cell therapy to counteract this and other degenerative diseases in dogs.
"The stem cells from the patient are the ones that are going to benefit that same patient versus trying to take stem cells from a different dog and putting them in this dog," said Dr. Williams. "By harvesting the stem cells from the fat versus people have heard of stem cells from umbilical cords and stuff like that we're taking it from the fat tissue and harvesting those and actually activating with a fluorescent light."
Once the fat is extracted it's a two hour process to prepare the new stem cells. Those are then injected back into the patient along with platelets that work with the immune system to fight the disorder.
SIKESTON, MO (KFVS) -
Stem cell therapycan bea very controversial issue, but now some veterinarians are using new techniques to harvest those cells.
The cutting edge procedure helps fight degenerative diseases and has only been performed a few times in Missouri.
Experts say regenerative medicine using stem cells is a less invasive and more cost effective alternative for dogs suffering from osteoarthritis and cartilage injuries.
Googus is an 8 year old Boxer mix diagnosed with degenerative myelopathy.
This terminal disease affects the spinal cord causing loss of control in the hind legs.
"Even though they're unable to use their back legs they're still normal in their brain and they just don't understand why they can't walk," said Dr. Stephen Williams, Animal Health Center. "There's just not a good connection and transmission from the nerves to the back legs."
But new technology could slow, if not stop, its progression. Dr. Williams is using stem cell therapy to counteract this and other degenerative diseases in dogs.
"The stem cells from the patient are the ones that are going to benefit that same patient versus trying to take stem cells from a different dog and putting them in this dog," said Dr. Williams. "By harvesting the stem cells from the fat versus people have heard of stem cells from umbilical cords and stuff like that we're taking it from the fat tissue and harvesting those and actually activating with a fluorescent light."
Once the fat is extracted it's a two hour process to prepare the new stem cells. Those are then injected back into the patient along with platelets that work with the immune system to fight the disorder.
Read more here:
Stem cell therapy used in Sikeston in dogs
PUBLIC RELEASE DATE:
22-Oct-2013
Contact: Eileen Leahy e.leahy@elsevier.com 732-238-3628 Elsevier Health Sciences
San Francisco, CA, October 22, 2013 A study performed at Children's Hospital Los Angeles found no evidence that stem cell therapy improves vision for children with optic nerve hypoplasia (ONH). Their results are reported in the Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS).
ONH, an underdevelopment of optic nerves that occurs during fetal development, may appear either as an isolated abnormality or as part of a group of disorders characterized by brain anomalies, developmental delay, and endocrine abnormalities. ONH is a leading cause of blindness in children in North America and Europe and is the only cause of childhood blindness that shows increasing prevalence. No treatments have been shown to improve vision in these children.
With no viable treatment options available to improve vision, ophthalmologists are becoming aware that families with children affected by ONH are travelling to China seeking stem cell therapy, despite lack of approval in the United States and Europe or evidence from controlled trials. The American Association for Pediatric Ophthalmology and Strabismus has also expressed its concern about these procedures. In response to this situation, pediatric neuro-ophthalmologist Mark Borchert, MD, Director of both the Eye Birth Defects and Eye Technology Institutes in The Vision Center at Children's Hospital Los Angeles, realized that a controlled trial of sufficient size was needed to evaluate whether stem cell therapy is effective at improving optic nerve function in children with ONH. He agreed to conduct an independent study when asked by Beike Biotech, a company based in Shenzhen, China, that offers treatment for ONH using donor umbilical cord stem cells injected into the cerebral spinal fluid.
Beike Biotech agreed to identify 10 children with bilateral ONH (ages 7-17 years) who had volunteered to travel to China for stem cell therapy and who agreed to participate in the study; Children's Hospital was to find case matched controls from their clinic. However, only two case-controlled pairs were evaluated because Beike Biotech was only able to recruit two patients. Treatments consisted of six infusions over a 16-day period of umbilical cord-derived mesenchymal stem cells and daily infusions of growth factors. Visual acuity, optic nerve size, and sensitivity to light were to be evaluated one month before stem cell therapy and three and nine months after treatment.
No therapeutic effect was found in the two case-control pairs that were enrolled. "The results of this study show that children greater than 7 years of age with ONH may have spontaneous improvement in vision from one examination to the next. This improvement occurs equally in children regardless of whether or not they received treatment. Other aspects of the eye examination included pupil responses to light and optic nerve size; these did not change following treatment. The results of this research do not support the use of stem cells in the treatment of ONH at this time," says lead author Cassandra Fink, MPH, program administrator at The Vision Center, Children's Hospital Los Angeles.
Confounding the trial was that subjects received additional alternative therapies (acupuncture, functional electrical stimulation, and exercise) while receiving stem cell treatments, which was contrary to the trial protocol. The investigators could not determine the effect of these additional therapies.
"This study underscores the importance of scientifically testing these procedures to validate them and also to ensure their safety. Parents of afflicted children should be aware that the science behind the use of stem cell technology is unclear. This study takes a step toward testing this technology and finds no beneficial effect," says William V. Good, MD, Senior Associate Editor, Journal of AAPOS and Clinical Professor of Ophthalmology and Senior Scientist at the Smith-Kettlewell Eye Research Institute.
Visit link:
No evidence to support stem cell therapy for pediatric optic nerve hypoplasia
Orange County, CA (PRWEB) October 21, 2013
The premier stem cell therapy clinic on the West Coast, Physician First Choice, is now offering IV stem cell treatment for numerous medical conditions. This includes stem cell treatment for Alzheimer's disease, Diabetes, Parkinson's, Liver Disease, Cardiac Disease, COPD and much more. The treatments are provided by US Board Certified Stem Cell Doctors and for more information call (888) 988-0515.
Stem cell therapy has become available for numerous medical conditions and can dramatically improve the patient's baseline. Increasing amounts of research are showing the benefits of IV stem cell therapy for conditions such as diabetes and COPD. Prior to stem cell therapy, these conditions could be managed with traditional medications, but the disease itself could not be altered. With stem cell therapy, that possibility exists.
The Board Certified stem cell doctors at Physician First Choice have over 20 combined years of experience working with patients for both stem cell injection treatment and IV therapy. The clinic treats patients at multiple Southern California locations along with an international location in Mexico. Patient treatment is performed by the same US Board Certified doctors before, during and after therapy to ensure continuity of care.
The program in Mexico involves four days worth of treatment at a first rate clinic, and patients stay at a beautiful hotel with transportation included. IV stem cell therapy is performed along with growth factor treatments to enhance the effect of the bone marrow stem cells.
For conditions such as multiple sclerosis, Alzheimer's or Parkinson's, watching a loved one deteriorate can be disheartening even when the best care is received. Physician First Choice has been having excellent results with IV stem cell treatment for diabetes and these conditions, and the program has been growing exponentially as a result.
The 4 Day Stem Cell Therapy IV Program is offered as a package. Transportation to and from San Diego is included along with the Hotel Stay, All Medical Treatment, Breakfast Each Day, and Transportation between the Gorgeous Hotel and the Stem Cell Treatment Facility. Patients must be approved for program inclusion with a full medical record review and evaluation by the Southern California doctors.
To inquire about program inclusion for IV stem cell therapy, call Physician First Choice at (888) 988-0515.
Follow this link:
Physician First Choice Now Offering IV Stem Cell Therapy for Numerous Medical Conditions with US Board Certified Stem ...
Mathew Blurton Jones - New Hope: Stem Cell Therapy in Alzheimer #39;s Disease
"New Hope: Stem Cell Therapy in Alzheimer #39;s Disease" Mathew Blurton-Jones, Ph.D. -- University of California, Irvine 24th Annual Southern California Alzheime...
By: UCITLTC
See the original post here:
Mathew Blurton Jones - New Hope: Stem Cell Therapy in Alzheimer's Disease - Video
Stem Cell Therapy in India for Osteoarthritis
Completely bedridden patient have started joint movements after transplantation of autologous stem cells intra thically and thhough IV. His stem cell transpl...
By: StemRx BioScience
Read the original:
Stem Cell Therapy in India for Osteoarthritis - Video
Stem cell therapy in India for Avascular Necrosis (AVN)
Avascular necrosis can be completely treated with stem cell therapy. Stem cell therapy provided at StemRx Bioscience solutions is strong alternative option f...
By: StemRx BioScience
See the original post:
Stem cell therapy in India for Avascular Necrosis (AVN) - Video
Johns Hopkins Medicine Media Relations and Public Affairs
JOHNS HOPKINS MEDICINE NEWS TIPS FROM THE 2013 ANNUAL CLINICAL CONFERENCE OF THE AMERICAN COLLEGE OF SURGEONS, OCT. 6-10, WASHINGTON, D.C.
GENE AND STEM CELL THERAPY COMBINATION COULD AID WOUND HEALING
--Findings in elderly mice offer insight into helping elderly people recover from burns
Newswise Johns Hopkins researchers, working with elderly mice, have determined that combining gene therapy with an extra boost of the same stem cells the body already uses to repair itself leads to faster healing of burns and greater blood flow to the site of the wound.
Their findings offer insight into why older people with burns fail to heal as well as younger patients, and how to potentially harness the power of the bodys own bone marrow stem cells to reverse this age-related discrepancy.
As we get older, it is harder for our wounds to heal, says John W. Harmon, M.D., a professor of surgery at the Johns Hopkins University School of Medicine, who will present his findings to the American College of Surgeons Surgical Biology Club on Sunday at 9 a.m. Our research suggests there may be a way to remedy that.
To heal burns or other wounds, stem cells from the bone marrow rush into action, homing to the wound where they can become blood vessels, skin and other reparative tissue. The migration and homing of the stem cells is organized by a protein called Hypoxia-Inducible Factor-1 (HIF-1). In older people, Harmon says, fewer of these stem cells are released from the bone marrow and there is a deficiency of HIF-1. The protein was first discovered about 15 years ago at Johns Hopkins by Gregg L. Semenza, M.D., Ph.D., one of Harmons collaborators.
Harmon and his colleagues first attempted to boost the healing process in mice with burn wounds by increasing levels of HIF-1 using gene therapy, a process that included injecting the rodents with a better working copy of the gene that codes for the protein. That had worked to improve healing of wounds in diabetic animals, but the burn wound is particularly difficult to heal, and that approach was insufficient. So they supplemented the gene therapy by removing bone marrow from a young mouse and growing out the needed stem cells in the lab. When they had enough, they injected those supercharged cells back into the mice.
After 17 days, there were significantly more mice with completely healed burns in the group treated with the combination therapy than in the other groups, Harmon says. The animals that got the combination therapy also showed better blood flow and more blood vessels supplying the wounds.
Read this article:
Gene and Stem Cell Therapy Combination Could Aid Wound Healing
Purtier Placenta Live stem Cell Therapy Miracle - Mr Wilson Grandma is healthy now after 8 months
This video is from YouTube Channel-wilsonho ho. In his YouTube Wilson never mentions much. Just a short message, My grandmother is healthy now after 8months ...
By: Purtier Placenta Singapore Original
Stem Cell Therapy Treatment for Mild Autism by Dr Alok Sharma, Mumbai, India
Improvement seen in just 5 days after Stem Cell Therapy Treatment for Mild Autism by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy As reported by th...
By: Neurogen Brain and Spine Institute
Read the original:
Stem Cell Therapy Treatment for Mild Autism by Dr Alok Sharma, Mumbai, India - Video
Freeport, The Bahamas (PRWEB) October 03, 2013
Okyanos Heart Institute, whose mission is to bring a new standard of care and better quality of life to patients with coronary artery disease using cardiac stem cell therapy, has announced that they will be hosting a free educational seminar for the business community and all other interested individuals on Tuesday, October 22nd from 5:30 6:30 pm in the Coral Reef Room of the Pelican Bay Hotel in Lucaya, Grand Bahama Island. Registration is requested to attend as seating is limited.
Howard Walpole, M.D., M.B.A., F.A.C.C., F.S.C.A.I. and chief medical officer and interventional cardiologist for Okyanos Heart Institute will provide an overview of stem cell therapy for heart disease, the source of stem cells, how it is intended to work, and the protocol that will be used by the cath lab for patients once the facility is open in February, 2014. Erika Mangrum, SVP of Communications for the company, will provide an overview of what services will be needed by small businesses on the island, such as janitorial, hospital grade laundry, transportation, catering and more. A preliminary list of jobs that Okyanos Heart Institute will need to fill towards the end of the year will also be shared.
We welcome the local business community to learn about what we will be doing in treating patients with heart disease, said Walpole. Stem cell therapy is a growing field still with some confusion around where stem cells come from, what they do, and how they can potentially help someone with heart disease. We want to answer as many questions as we can.
President of The Grand Bahama Port Authority, Limited (GBPA) Ian Rolle, is pleased with how plans are progressing as the Institute prepares to open its doors locally in early 2014. Legislation has recently been enacted to support stem cell therapy, research and development in The Bahamas. This is of monumental proportions as Grand Bahama Island is now poised to become a leading centre for medical advancement, Rolle said. We heartily welcome the Okyanos Heart Institute and support their efforts towards public education. Additionally, the employment of skilled professionals and outsourcing of ancillary services, mean permanent engagement and greater business opportunities for many of our citizenry.
Okyanos Heart Institute will have a number of service needs from the local business community, said Mangrum. We hope to meet potential suppliers and servicers and share what our needs will be from service providers, and share employment needs once we are close to opening in February. We could not be more enthused about bringing patients to the beautiful island of Grand Bahama in the hopes of improving the quality of their lives by restoring flow to their hearts.
Registration for the seminar is requested as seating is limited. Call 242-688-2667 or email freeseminar(at)okyanos(dot)com by Oct 18.
ABOUT OKYANOS HEART INSTITUTE: (Oh key AH nos) Based in Freeport, The Bahamas, Okyanos Heart Institutes mission is to bring a new standard of care and a better quality of life to patients with coronary artery disease using cardiac stem cell therapy. Okyanos adheres to U.S. surgical center standards and is led by Chief Medical Officer Howard T. Walpole Jr., M.D., M.B.A., F.A.C.C., F.S.C.A.I. Okyanos Treatment utilizes a unique blend of stem and regenerative cells derived from ones own adipose (fat) tissue. The cells, when placed into the heart via a minimally-invasive catheterization, stimulate the growth of new blood vessels, a process known as angiogenesis. The treatment facilitates blood flow in the heart and supports intake and use of oxygen (as demonstrated in rigorous clinical trials such as the PRECISE trial). The literary name Okyanos (Oceanos) symbolizes flow. For more information, go to http://www.okyanos.com.
Go here to see the original:
Okyanos Heart Institute Offers Educational Seminar About Cardiac Stem Cell Therapy In Lucaya, Grand Bahama
Insurance Covered Stem Cell Therapy in California at TeleHealth (888) 828-4575
http://stemcelltherapyincalifornia.com Stem Cell Therapy procedures at TeleHealth are offered for a number of conditions and often covered by insurance. Thes...
By: USPainNetwork
Continue reading here:
Insurance Covered Stem Cell Therapy in California at TeleHealth (888) 828-4575 - Video
Professor Arnold Caplan discusses mesenchymal stem cell therapy for multiple sclerosis
Professor Caplan is "The father of the mesenchymal stem cell (MSC)". In this clip, he describes a mouse experiment using human MSCs in a mouse model of MS. T...
By: http://www.cellmedicine.com
See original here:
Professor Arnold Caplan discusses mesenchymal stem cell therapy for multiple sclerosis - Video
MANILA, PhilippinesStem cell therapy should only apply to skin grafting for burn patients and not for anti-aging purposes, according to the Food and Drug Administration (FDA).
Up to now, there is no evidence that stem cell therapy has anti-aging effects, said FDA acting Director General Kenneth Hartigan-Go.
The FDA recognizes only hematopoietic (pertaining to the formation and development of blood cells) stem cell transplantation, corneal resurfacing with limbal stem cells and skin regeneration with epidermal stem cells as generally accepted standards of health care.
Asked if this meant anti-aging stem cell therapies would not be allowed in the Philippines, Go said: It means that if the health claim is for burn patients, requirements that need to be submittedlike clinical trial reportsare expected to be complete, whereas if the claim is for anti-aging, then the requirements may be more extensive and intensive considering that products for anti-aging claims are still controversial.
Facility accreditation
The FDA said it had been continuously collaborating with the Department of Healths Bureau of Health Facilities and Services (BHFS) in accrediting facilities that deal with human cells, tissues, and cellular and tissue-based products (HCT/Ps), laboratory and therapeutic activities or services.
As of Sept. 24, 51 facilities have applied for accreditation, and 11 of these have been inspected by the BHFS, the FDA said.
No automatic approval
Submission of an application, however, does not necessarily result in automatic approval.
The FDA guidelines require that all stem cell and cellular-based treatments offered in the country should first pass the agencys standards for safety, efficacy and quality.
Here is the original post:
Stem cell therapy for burns, not aging, says FDA
Orange, CA (PRWEB) September 30, 2013
TeleHealth, the leading stem cell therapy clinic on the West Coast, is now offering multiple treatments with stem cells for knee arthritis. The stem cell treatments are very exciting as they present the possibility of repairing and regenerating arthritis damage in the knees. The treatments are offered by Board Certified stem cell doctors at the clinic in outpatient, low risk procedures that are often covered by insurance. Call (888) 828-4575 for more information and scheduling.
Over the past few years, increasing studies are showing the benefits of regenerative medicine treatments for knee arthritis. This includes a study out of the Hospital for Special Surgery last year showing effectiveness of platelet rich plasma therapy for knee arthritis. Treatment options at TeleHealth include both platelet rich plasma therapy (PRP therapy) along with bone marrow derived stem cell injection therapy or fat derived stem cell therapy.
Often, the treatments are combined to produce maximum knee arthritis benefit and allow patients to avoid surgery, reduce pain and dramatically increase functional ability. While knee replacement surgery has been shown to have a high success rate, the components are not meant to last forever and there can be complications with the surgery.
Therefore, it makes sense to try conservative treatment prior such as with the regenerative medicine options at TeleHealth. Especially considering the stem cell treatments are often covered by insurance.
TeleHealths main stem cell clinic is located in Orange, CA, convenient to major freeways and not far from San Diego, Los Angeles, Santa Ana and Inland Empire. The highly skilled stem cell doctors at the clinic are Board Certified and have years of experience treating musculoskeletal conditions with stem cell treatments including shoulder arthritis, rotator cuff tendonitis, Achilles tendonitis, tennis elbow, muscle tears and much more.
Call (888) 828-4575 for more information and scheduling.
See more here:
Southern California Stem Cell Therapy Clinic, TeleHealth, Now Offering Stem Cells for Knee Arthritis
In a step that brings stem cells closer to the clinic, researchers in Japan have found that transplanting reprogrammed stem cells into the brains of primates elicits little rejection by their immune systems.
Induced pluripotent stem cells (iPSCs) are created when skin cells, for example, are genetically reprogrammed to an embryonic-like state. This kind of stem cells holds great potential for the treatment of disease, since the cells are genetically identical to the patient they are taken from.
However, studies in rodents have suggested that the immune system may still recognize cells derived from iPSCs as foreign, and mount an attack on them. This has cast doubt on the feasibility of similar cell therapy for humans.
To test this in an animal more closely related to humans, researchers studied macaques. Using cells taken from the monkeys mouths or from their bloodstream, the researchers created iPSCs which they then, in turn, transformed into neurons. These neurons were of a specific kind: dopamine-producing neurons, the type depleted by Parkinsons disease.
Each monkey got six injections of these neurons into its brainsome which had been made from their own cells and others which were from another individual and therefore mismatched. The team could then see what kind of immune response each type produced.
Over subsequent months of observation, the monkeys showed very little immune response to transplants of their own cells. Their immune response was much higher in response to cells from another monkey.
The team also tracked how well the neurons survived after transplantation. They found that even when there was an immune response from the primate, the dopamine-producing neurons survived. The study is published today in Stem Cell Reports.
Trials using iPSCs to treat people with Parkinsons disease could therefore be on the horizon. These findings give a rationale to start autologous transplantationat least of neural cellsin clinical situations, says senior author Jun Takahashi of Kyoto University.
Image by Oliver Sved / Shutterstock
Continued here:
Stem Cell Therapy for Parkinson's Proves Safe in Primates
Poway, California (PRWEB) September 24, 2013
Vet-Stem, Inc., the world's leading Regenerative Veterinary Medicine company, is pleased to announce that Pets Best Insurance plans provide coverage for Regenerative Stem Cell Therapy. Pets Best Insurance knows that with pets come vet bills, especially when a pet is suffering from the pain of injury or arthritis. Pets Best Insurance wants the best for pets and their owners and Vet-Stem offers the best in regenerative medicine for them. Pets suffering from pain of osteoarthritis, joint issues, and injuries of the muscle, tendon and ligament can now be given stem cell therapy.
Vet-Stem first offered stem cell therapy for dogs and cats in 2007. One of the success stories and stem cell advocates is part of the Pets Best Insurance family, Jetta, owned by Greg McDonald, CEO of Pets Best Insurance.
Jack L. Stephens, DVM and President/Founder of Pets Best Insurance talks about Gregs experience: "Our CEO had a wonderful experience utilizing Vet-Stem therapy in his twelve year old lab. He loved throwing, and she loved chasing, a ball every evening. But as she aged, she just could not do it due to severe arthritis. Surgery was not a viable alternative and he asked me about stem cell therapy. I told him we had seen claims with the treatment and it was covered with our insurance. He had it done, her condition very much improved and she was able to chase the ball again. Pets Best Insurance provides full coverage for Vet-Stem Regenerative Cell Therapy, in fact we were early adopters of providing coverage and paying for the therapy. Any procedure performed by practicing veterinarians that helps pets, we are in favor of.
"We are proud that so many dog owners and veterinarians have placed their trust in Vet-Stem Cell therapy. We feel a great sense of accomplishment knowing that there are thousands of dogs and dog owners who have experienced the benefit of stem cell technology. This practical and beneficial application of technology puts stem cell therapy into the present day instead of a future theoretical concept. The fact that Pets Best provides coverage for our therapy is an added plus and makes this a viable treatment option for many more pet owners," said Robert Harman, DVM, MPVM, Founder and CEO of Vet-Stem.
For more information about Pets Best Insurance visit http://www.petsbest.com
About Vet-Stem, Inc. Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine. The company holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In the last decade over 10,000 animals have been treated using Vet-Stem, Inc.s services, and Vet-Stem is actively investigating stem cell therapy for immune-mediated and inflammatory disease, as well as organ disease and failure. For more on Vet-Stem, Inc. and Veterinary Regenerative Medicine visit http://www.vet-stem.com or call 858-748-2004.
Go here to see the original:
Pets Best Insurance Announces Stem Cell Therapy and Regenerative Veterinary Medicine by Vet-Stem, Inc. Covered by ...
Orange County, CA (PRWEB) September 23, 2013
The leading regenerative medicine clinic on the West Coast, TeleHealth, is now offering three different types of stem cell therapy injections. The California stem cell treatments are predominantly covered by insurance, and performed by Board Certified stem cell doctors. For more information and scheduling, call (888) 828-4575.
The stem cell treatments are excellent for joint arthritis, tendonitis, ligament injuries, and spinal arthritis along with degenerative disc disease. Initial research with small studies has shown regenerative medicine treatments are working well for degenerative conditions, such as the recent study out of the Hospital for Special Surgery.
One of the treatments offered is bone marrow derived stem cell injections. These are outpatient procedures that involve harvesting the patient's own bone marrow, processing it, and injecting into the area of concern at the same setting. These bone marrow stem cell injections have very low risk and the potential for helping regenerate damaged cartilage and soft tissue from such conditions as achilles tendonitis, rotator cuff tendonitis and tennis elbow.
The second procedure offered is platelet rich plasma therapy. This procedure involves a simple blood draw from the patient, and the blood is centrifuged for approximately 15 minutes. This separates the blood into concentrated platelets and growth factors, which are then injected into the problem area. This material then calls in the body's stem cells to facilitate further repair. At times PRP is used in conjunction with bone marrow derived stem cell injections.
The third procedure utilized is fat derived stem cell injections, which has the same indications as bone marrow derived.
TeleHealth sees patients from a broad area of the west coast and offers Board Certified doctors providing treatment. To seek treatment with the premier stem cell therapy clinic, call (888) 828-4575.
Read more here:
Leading Stem Cell Clinic in California, TeleHealth, Now Offering 3 Different Stem Cell Therapy Treatments